CIK 0001818844 · Non-accelerated filer<br>Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 854314201
- Phone
- 8666208655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- 4 Derivatives Options or other derivatives
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Chief Executive Officer bought 382 shares at $6.36 ($2,429)
- 4/A Open-market buy Chief Executive Officer bought 15,675 shares at $6.17 ($96,757)
- 4 Open-market buy Chief Executive Officer bought 15,675 shares at $6.17 ($96,757)
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy VP of Finance bought 1,000 shares at $7.30 ($7,300)
- 4 Open-market buy Director bought 3,500 shares at $7.47 ($26,145)
Page 14 of 17 · 331 filings